Access and Inclusion in Psychedelic Treatment

Psychedelic-assisted therapy is making its way through the established medical system’s approval process and moving towards becoming an available treatment for conditions such as PTSD and Depression. This comes after years of prohibition of psychedelics through international drug conventions and local laws often disproportionately enforced in marginalized communities. As states and regulatory bodies consider making psychedelic-assisted therapy available, key social justice considerations come into focus, particularly around healthcare disparities and access to treatment, medicalization of plants that certain communities consider sacred, oppressive psychiatric treatments, and stigma experienced by people who use drugs.

The webinar series will cover a range of topics about both the present challenges and future opportunities for addressing social injustice in the field of psychedelic medicine, focusing on the role of the clinician’s voice in the context of the larger healthcare system. The instructors and panelists will contribute their own unique perspectives and insights into the social justice implications of psychedelic-assisted therapy, research, and treatment. Throughout the series, participants will be encouraged to bring curiosity and openness to their own experiences, with a focus on developing insight and understanding based therein. To encourage ongoing reflection and engagement with the material participants will be invited to complete various exercises to clarify their reaction to the material, what they have learned and how they desire to incorporate these insights into their lives going forward.